Compare Becton Dickinson and Co (BDX) vs Southern Copper Corp (SCCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs Southern Copper Corp — how do they compare? Becton Dickinson and Co trades at $181.29 (market cap $48.93B), while Southern Copper Corp trades at $195 (market cap $166.96B). The key difference: Southern Copper Corp is far larger — about 3.4× Becton Dickinson and Co's market cap, and Becton Dickinson and Co pays the higher dividend (2.34%). Which is the better fit depends on your goals.
| BDX | SCCO | |
|---|---|---|
Market Cap | $48.93B | $166.96B |
Sector | Health | Basic Materials |
52-Week High | $185.39 | $218.85 |
52-Week Low | $138.62 | $93.70 |
Enterprise Value | $65.03B | $168.25B |
Dividend Yield | 2.34% | 2.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX (Becton, Dickinson and Company) trades at $176.86, down 0.12% on the day, with a bullish technical outlook supported by moving averages and strong earnings beats in recent quarters. The company reported Q3 2026 revenue of $5.0 billion, up 4.4% FX-neutral, and raised full-year guidance, though margins faced pressure. Analyst sentiment is mixed with a consensus price target of $183.00, while institutional ownership remains stable amid positive news on GLP-1 therapy expansions and dividend declarations.
The stock offers steady growth potential with a 2.7% dividend yield and consistent earnings outperformance, but risks include margin compression, regulatory recalls, and high valuation multiples. Near-term resistance at $180 and support at $173 will test bullish momentum, with the current price near the consensus target suggesting limited upside without further catalysts.
Southern Copper (SCCO) trades at $199.06, up 3.12% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with Q2 2026 EPS beating expectations at $2.01 vs. $1.98, revenue growth from $13.42B in 2025 to projected $15.8B in 2026, and exceptional profitability with 35.87% net margin. Recent corporate actions include dividends and stock splits, while institutional activity shows increased positions from Dimensional Fund Advisors and CalPERS.
SCCO presents growth potential driven by strong earnings performance and AI-driven copper demand, but faces risks from analyst skepticism (41.38% sell ratings) and valuation concerns with P/E of 29.51. The stock trades above consensus price target of $153.64, suggesting limited near-term upside despite positive technical momentum and fundamental strength.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About Southern Copper Corp
Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. Southern Copper generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. Its geographical segments are The Americas, Europe, and Asia.
Read more on SCCO →
